HEPERAIN 50 mg/50 mL (1mg/mL) Injectable Solution, Heparin Sodium 0.45% Sodium Chloride QS Hepari...

FDA Drug Recall #D-0430-2019 — Class II — January 15, 2019

Recall Summary

Recall Number D-0430-2019
Classification Class II — Moderate risk
Date Initiated January 15, 2019
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Advanced Pharma Inc.
Location Houston, TX
Product Type Drugs
Quantity 160 syringes

Product Description

HEPERAIN 50 mg/50 mL (1mg/mL) Injectable Solution, Heparin Sodium 0.45% Sodium Chloride QS Heparin 50 Units 50 mL, Sterile single use syringe, Avella of Houston an FDA Registered 503B Outsourcing Facility 9265 Kirby Dr. Houston, TX 77054 (877) 794-0404 ---- NDC: 42852-725-65

Reason for Recall

Labeling; Label Error on Declared Strength; label incorrectly states the concentration as 50 mg/50 mL (1 mg/mL) rather than the fully accurate concentration as 50 Units/50 mL (1 Unit/mL)

Distribution Pattern

TX, WA

Lot / Code Information

Lot: 12/19/18 0242 72565S BUD: 3/31/19

Other Recalls from Advanced Pharma Inc.

Recall # Classification Product Date
D-1251-2019 Class II HYDROmorphone 20 mg/100 mL Injectable Solution,... Apr 26, 2019
D-1023-2019 Class II Phenylephrine HCl, 1 mg in 0.9% Sodium Chloride... Mar 13, 2019
D-1017-2019 Class II fentaNYL 1000 mcg/100 mL Injectable Solution Fe... Mar 13, 2019
D-1026-2019 Class II 2% Lidocaine HCl Injectable Solution, 60 mg/3 m... Mar 13, 2019
D-1033-2019 Class II Morphine Sulfate 30 mg/30 mL (1 mg/mL) Injectab... Mar 13, 2019

Frequently Asked Questions

Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.